曠達科技(002516.SZ):捐款100萬元 用於抗擊新型冠狀病毒肺炎疫情
格隆匯2月7日丨曠達科技(002516.SZ)公佈,近來,新型冠狀病毒疫情引發全國人民關注。面對疫情防控嚴峻形勢,公司積極響應中央“疫情就是命令,防控就是責任”的號召,制定《新型冠狀病毒肺炎疫情防控應急預案》等詳細的防疫類制度文件,同時做好其他疫情防控阻擊工作。
在積極做好企業疫情防控的同時,公司用實際行動助力疫情防控阻擊戰。公司於2020年2月7日向武漢市慈善總會捐款人民幣100萬元,所捐款項將專項用於抗擊新型冠狀病毒肺炎疫情;另外,公司下屬全資公司柳州曠達汽車飾件有限公司將在柳州市柳北區工信局的組織和指導下進行口罩縫製加工支持抗疫。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.